Variant report
Variant | nsv968235 |
---|---|
Chromosome Location | chr5:115106356-115107150 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:114970470..114971000-chr5:115106287..115106794,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AP3S1-7 | chr5:115106283-115106686 | NONHSAT103323 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10069550 | chr5:115106428-115106429 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs539333603 | chr5:115106442-115106443 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs546521029 | chr5:115106455-115106456 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs564391303 | chr5:115106472-115106473 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs564376925 | chr5:115106478-115106479 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs143007268 | chr5:115106557-115106558 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs147535833 | chr5:115106612-115106613 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs575645290 | chr5:115106622-115106623 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs368429284 | chr5:115106629-115106630 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs540827973 | chr5:115106631-115106632 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs578090790 | chr5:115106645-115106646 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs140223460 | chr5:115106704-115106705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560782685 | chr5:115106705-115106706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547042959 | chr5:115106722-115106723 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143976988 | chr5:115106789-115106790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542857107 | chr5:115106797-115106798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568448356 | chr5:115106803-115106804 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs888859 | chr5:115106833-115106834 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs144320201 | chr5:115106846-115106847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533474397 | chr5:115106885-115106886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563907556 | chr5:115106896-115106897 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191618850 | chr5:115106924-115106925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546445549 | chr5:115106978-115106979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566441509 | chr5:115106997-115106998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183476996 | chr5:115107028-115107029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76213056 | chr5:115107035-115107036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186086296 | chr5:115107063-115107064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148777080 | chr5:115107075-115107076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:115091800-115117200 | Weak transcription | Liver | Liver |
2 | chr5:115103200-115107200 | Weak transcription | Adipose Nuclei | Adipose |
3 | chr5:115106000-115106600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr5:115106200-115106400 | Enhancers | Fetal Muscle Trunk | muscle |
5 | chr5:115106200-115109000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr5:115106400-115108800 | Weak transcription | Fetal Muscle Trunk | muscle |
7 | chr5:115106400-115112000 | Enhancers | Fetal Muscle Leg | muscle |